Physician profile
Juris E Treibergs
NPI 1790760098
$27,851.29
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $11K · 2021: $88.04 · 2022: $111.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $26,251.16 | 2019-2020 | |
| Allergan, INC. | $277.68 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $229.48 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $220.09 | 2019-2020 | |
| Lundbeck LLC | $163.92 | 2019-2020 | |
| Alkermes, INC. | $128.50 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.79 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $107.39 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $82.33 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $73.38 | 2019 | |
| Merck Sharp & Dohme LLC | $62.28 | 2019-2020 | |
| Tris Pharma INC | $45.56 | 2019-2020 | |
| Neuronetics, INC. | $27.35 | 2020 | |
| Neos Therapeutics, LP | $26.73 | 2020 | |
| Abbvie INC. | $16.55 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.54 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juris Treibergs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.